Permitting Product Liability Litigation for FDA‐Approved Drugs and Devices Promotes Patient Safety
暂无分享,去创建一个
[1] D. Vladeck. A Critical Examination of the FDA's Efforts to Preempt Failure-to-Warn Claims , 2007 .
[2] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[3] DE Mager,et al. Development of Translational Pharmacokinetic–Pharmacodynamic Models , 2008, Clinical pharmacology and therapeutics.
[4] S. Albani,et al. The advancement of translational medicine—from regional challenges to global solutions , 2009, Nature Medicine.
[5] W. Maisel,et al. Semper fidelis--consumer protection for patients with implanted medical devices. , 2008, The New England journal of medicine.
[6] D. Stoff,et al. Moving toward paradigm-shifting research in health disparities through translational, transformational, and transdisciplinary approaches. , 2010, American journal of public health.
[7] M. Piquette-Miller,et al. Translational Pharmacology: Harnessing Increased Specialization of Research Within the Basic Biological Sciences , 2008, Clinical pharmacology and therapeutics.
[8] D. Abernethy,et al. Finding the Right Research Question: Quality Science Depends on Quality Careers , 2008, Clinical pharmacology and therapeutics.
[9] J. Wyngaarden. The president's address. "The clinical investigator as an endangered species". , 1979, Transactions of the Association of American Physicians.
[10] Aaron S Kesselheim,et al. The role of litigation in defining drug risks. , 2007, JAMA.
[11] Y. Aulchenko,et al. A powerful genome-wide feasible approach to detect parent-of-origin effects in studies of quantitative traits , 2010, European Journal of Human Genetics.